Found: 28
Select item for more details and to access through your institution.
Rituximab or a second anti-tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti-tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register.
- Published in:
- 2012
- By:
- Publication type:
- journal article
EFFICACY AND SAFETY OF ANTI-TNF THERAPIES IN PSORIATIC ARTHRITIS: AN OBSERVATIONAL STUDY FROM THE BRITISH SOCIETY FOR RHEUMATOLOGY BIOLOGICS REGISTER.
- Published in:
- Romanian Journal of Rheumatology / Revista Romana de Reumatologie, 2010, v. 19, n. 2, p. 123
- By:
- Publication type:
- Article
Outcomes following switching from etanercept originator to etanercept biosimilar in 1024 patients with RA: a matched-analysis of the BSRBR-RA.
- Published in:
- Rheumatology, 2024, v. 63, n. 8, p. 2082, doi. 10.1093/rheumatology/kead470
- By:
- Publication type:
- Article
Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying anti-rheumatic drugs: does line of therapy matter?
- Published in:
- Rheumatology, 2024, v. 63, n. 7, p. 1957, doi. 10.1093/rheumatology/kead515
- By:
- Publication type:
- Article
Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA.
- Published in:
- Rheumatology, 2023, v. 62, n. 12, p. 3849, doi. 10.1093/rheumatology/kead127
- By:
- Publication type:
- Article
Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
- Published in:
- Rheumatology, 2020, v. 59, n. 3, p. 559, doi. 10.1093/rheumatology/kez277
- By:
- Publication type:
- Article
O22 Frequency and reasons for switching back to etanercept originator following initial switch to etanercept biosimilar.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
- Published in:
- Rheumatology, 2018, v. 57, n. 9, p. 1533, doi. 10.1093/rheumatology/kex304
- By:
- Publication type:
- Article
Pregnancy outcomes in women with rheumatoid arthritis ever treated with rituximab.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor
The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis.
- Published in:
- Rheumatology, 2016, v. 55, n. 11, p. 2033, doi. 10.1093/rheumatology/kew314
- By:
- Publication type:
- Article
Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis treated with inhibitors of tumour necrosis factor α: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
- Published in:
- Rheumatology, 2016, v. 55, n. 7, p. 1336, doi. 10.1093/rheumatology/kew200
- By:
- Publication type:
- Article
Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register.
- Published in:
- Rheumatology, 2013, v. 52, n. 10, p. 1905, doi. 10.1093/rheumatology/ket248
- By:
- Publication type:
- Article
Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population.
- Published in:
- Rheumatology, 2013, v. 52, n. 1, p. 91
- By:
- Publication type:
- Article
The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Concurrent Oral 1 – Therapy of rheumatic disease.
- Published in:
- Rheumatology, 2011, v. 50, n. suppl_3, p. iii31, doi. 10.1093/rheumatology/ker073
- By:
- Publication type:
- Article
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special ...
- Published in:
- Rheumatology, 2011, v. 50, n. 1, p. 124
- By:
- Publication type:
- Article
Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008.
- Published in:
- Rheumatology, 2011, v. 50, n. 1, p. 117
- By:
- Publication type:
- Article
Comment on: Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register: reply.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register.
- Published in:
- Rheumatology, 2010, v. 49, n. 8, p. 1570, doi. 10.1093/rheumatology/keq131
- By:
- Publication type:
- Article
Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register.
- Published in:
- Rheumatology, 2010, v. 49, n. 4, p. 697, doi. 10.1093/rheumatology/kep423
- By:
- Publication type:
- Article
Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register.
- Published in:
- Rheumatology, 2010, v. 49, n. 3, p. 563, doi. 10.1093/rheumatology/kep422
- By:
- Publication type:
- Article
Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity.
- Published in:
- Rheumatology, 2009, v. 48, n. 10, p. 1323, doi. 10.1093/rheumatology/kep242
- By:
- Publication type:
- Article
Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
- Published in:
- Health & Quality of Life Outcomes, 2010, v. 8, p. 21, doi. 10.1186/1477-7525-8-21
- By:
- Publication type:
- Article
Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 6, p. 1337, doi. 10.1002/art.39582
- By:
- Publication type:
- Article